Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Bromfenac Sodium

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT05626478Phase 4Completed

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

Showing all 1 trials

Research Network

Common Treatments

  • Bromfenac Sodium1
  • Dexamethasone1
  • Prednisolone Acetate 1 Oph Susp1

Active Sponsors

  • Nicole Fram M.D.1

Top Investigators

Related Conditions

  • Corneal Edema1
  • Ocular Pain1
  • Anterior Chamber Inflammation1
  • Corneal Staining1
  • Visual Outcome1

Activity Timeline